Search Results 81-90 of 9890 for Clostridioides difficile infection

1. A Study Of C. Difficile Toxin B Levels After SoC Antibiotic Treatment - Mayo Clinic

   About this study. The purpose of this study is investigate the incidence of recurrence of C. difficile infection over 8 weeks following standard of care ...

2. A Study Of VE303 For Prevention Of Recurrent Clostridium Difficile Infection - Mayo Clinic

   difficile infection (pCDI) at high risk for recurrence or subjects with recurrent C. difficile infections (rCDI). Participation eligibility. Participant ...

3. Mayo Clinic enrolls first patient in phase 1 study of orally delivered capsule to treat recurrent Clostridium difficile infection

   “C-diff infections are an increasingly difficult-to-resolve intestinal infection that cause about 29,000 deaths annually in the U.S.,” says Dr. Khanna. Dr.

4. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection - Mayo Clinic

   This study will evaluate additional efficacy and safety information about RBX2660 for the treatment of recurrent Clostridium difficile infection (CDI).

5. Mucous Membrane Diseases Clinical Trials - Mayo Clinic Research

   The purpose of this study is to characterize the mucosal microbiome in patients who have recently been treated for Clostridium-difficile Infection (CDI) in ...

6. Efficacy Of Oral Vancomycin Prophylaxis For Prevention Of Recurrent Clostridium Difficile Infection - Mayo Clinic

   This study evaluates the efficacy of prophylaxis with oral vancomycin for preventing recurrent Clostridium difficile Infection (CDI) in patients who have ...

7. Fecal Microbiota Transplantation For C. Difficile Infection In Solid Organ Transplant Recipients - Mayo Clinic

   The purpose of this trial is to examine the effect of Fecal Microbiota Transplantation (FMT) compared with Vancomycin for cure of recurrent C. diff infection ( ...

8. Fecal microbiota, live-jslm (rectal route) - Side effects & uses - Mayo Clinic

   Clostridioides difficile infection (CDI) from coming back in patients who had received an antibiotic treatment. C. diff is a type of bacteria that causes ...

9. ECOSPOR III - SER-109 Versus Placebo In The Treatment Of Adults With Recurrent Clostridium Difficile Infection - Mayo Clinic

   Clinical Trials · ECOSPOR III - SER-109 Versus Placebo In The Treatment Of Adults With Recurrent Clostridium Difficile Infection · More about research at Mayo ...

10. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection - Mayo Clinic

    This study will evaluate efficacy and safety information about RBX2660 for the treatment of recurrent Clostridium difficile infection (CDI). Enrolled ...